Tumor | Author | Year | Method | No. of Patients | Title | Journal | Abstract Link |
Soft Tissue Sarcoma | Lindner | 2021 | HT | # | Perioperative chemotherapy and regional hyperthermia for high-risk adult-type soft tissue sarcomas | Eur J Cancer | |
Soft Tissue Sarcoma | Issels | 2021 | CT+HT | 109 | Immune infiltrates in patients with localised high-risk soft tissue sarcoma treated with neoadjuvant chemotherapy without or with regional hyperthermia: A translational research program of the EORTC 62961-ESHO 95 randomised clinical trial | Eur J Cancer | |
Soft Tissue Sarcoma | Issels | 2020 | HT | 109 | Systemic antitumor effect by regional hyperthermia combined with low-dose chemotherapy and immunologic correlates in an adolescent patient with rhabdomyosarcoma – a case report | Int J Hyperthermia | |
Soft Tissue Sarcoma | Bücklein | 2020 | ICE+HT | 110 | Ifosfamide, Carboplatin, and Etoposide (ICE) in Combination with Regional Hyperthermia as Salvage Therapy in Patients with Locally Advanced Nonmetastatic and Metastatic Soft-Tissue Sarcoma | Sarcoma | |
Soft Tissue Sarcoma | Aklan | 2019 | HT | # | Regional deep hyperthermia: quantitative evaluation of predicted and direct measured temperature distributions in patients with high-risk extremity soft-tissue sarcoma | Int J Hyperthermia | |
Soft Tissue Sarcoma | Zschaeck | 2018 | CT+HT | 61 | Neoadjuvant chemotherapy plus radiation versus chemotherapy plus regional hyperthermia in high-grade soft tissue sarcomas: a retrospective comparison | Int J Hyperthermia | |
Soft Tissue Sarcoma | Issels | 2018 | CT vs. CT+HT |
341 | Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma: The EORTC 62961-ESHO 95 Randomized Clinical Trial. | JAMA | |
Soft Tissue Sarcoma | Eckert | 2017 | CT+HT | 42 | Radiotherapy and hyperthermia with curative intent in recurrent high risk soft tissue sarcomas | Int J Hyperthermia | |
Soft Tissue Sarcoma | Angele | 2014 | CT vs. CT+HT |
341 | Effectiveness of regional hyperthermia with chemotherapy for high-risk retroperitoneal and abdominal soft-tissue sarcoma after complete surgical resection: a subgroup analysis of a randomized phase-III multicenter study. | Ann Surg Oncol | |
Soft Tissue Sarcoma | Issels | 2010 | CT vs. CT+HT |
341 | Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. | Lancet | |
Soft Tissue Sarcoma | Schlemmer | 2010 | RCT+HT | 47 | Thermochemotherapy in patients with extremity high-risk soft tissue sarcomas (HR-STS) | Int J Hyperthermia | |
Soft Tissue Sarcoma | Fiegl | 2004 | CT+HT | 20 | Ifosfamide, carboplatin and etoposide (ICE) as second-line regimen alone and in combination with regional hyperthermia is active in chemo-pre-treated advanced soft tissue sarcoma of adults. | Int J Hyperthermia | |
Soft Tissue Sarcoma | Wendtner | 2002 | CT+HT | 58 | Response to neoadjuvant chemotherapy combined with regional hyperthermia predicts long-term survival for adult patients with retroperitoneal and visceral high-risk soft tissue sarcomas. | JCO | |
Soft Tissue Sarcoma | Issels | 2001 | CT+HT | 59 | Neoadjuvant chemotherapy combined with regional hyperthermia (RHT) for locally advanced primary or recurrent high-risk adult soft-tissue sarcomas (STS) of adults: long-term results of a phase II study. | Eur J Cancer | |
Soft Tissue Sarcoma | Wendtner | 2001 | RCT+HT | 54 | Treatment of primary, recurrent or inadequately resected high-risk soft-tissue sarcomas (STS) of adults: results of a phase II pilot study (RHT-95) of neoadjuvant chemotherapy combined with regional hyperthermia. | Eur J Cancer | |
Soft Tissue Sarcoma | Prosnitz | 1999 | RT+HT | 97 | The treatment of high-grade soft tissue sarcomas with preoperative thermoradiotherapy. | IJRO | |
Soft Tissue Sarcoma | Scully | 1994 | RT+HT | 40 | Clinical outcome after neoadjuvant thermoradiotherapy in high grade soft tissue sarcomas | J Surg Oncol | |
Soft Tissue Sarcoma | Issels | 1990 | CT+HT | 40 | Ifosfamide plus etoposide combined with regional hyperthermia in patients with locally advanced sarcomas: a phase II study. | JCO |
RT-Radiotherapy; HT-Hyperthermia; LHT-Local Hyperthermia; CHT-Chemothyperthermia; CTX-Chemotherapy; MMC-Mitomycin C; EHT; Endocavity Hyperthermia; IHT-Interstitial Hyperthermia; HIPEC-Heated Intraperitoneal Chemotherapy; RCT-RadioChemotherapy; BCG-Bacillus Calmette-Guerin; CRT-Conformal Radiotherapy